Literature DB >> 11515774

Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy.

L Piroth1, M Grappin, J M Petit, M Buisson, M Duong, P Chavanet, H Portier.   

Abstract

A longitudinal study found that the incidence of gynecomastia in HIV-infected male patients treated with highly active antiretroviral therapy was 0.8/100 patient-years, with a prevalence of 2.8% in those treated for > or = 2 y. Even though the physiopathology remains unclear, this study suggests that gynecomastia should be monitored in these patients.

Entities:  

Mesh：

Year:  2001        PMID： 11515774     DOI： 10.1080/00365540110026476

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  8 in total

Review 1.  Breast enlargement in Malawian males on the standard first-line antiretroviral therapy regimen: Case reports and review of the literature.

Authors:  A Kwekwesa; C Kandionamaso; N Winata; E Mwinjiwa; M Joshua; D Garone; R Bedell; J J van Oosterhout
Journal:  Malawi Med J       Date:  2015-09       Impact factor: 0.875

2.  HIV-associated lipodystrophy syndrome: A review of clinical aspects.

Authors:  Jean-Guy Baril; Patrice Junod; Roger Leblanc; Harold Dion; Rachel Therrien; Franãois Laplante; Julian Falutz; Pierre Côté; Marie-Nicole Hébert; Richard Lalonde; Normand Lapointe; Dominic Lévesque; Lyse Pinault; Danielle Rouleau; Cécile Tremblay; Benoãt Trottier; Sylvie Trottier; Chris Tsoukas; Karl Weiss
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

3.  Gynaecomastia associated with highly active antiretroviral therapy (HAART).

Authors:  Debra Meerkotter
Journal:  J Radiol Case Rep       Date:  2010-07-01

Review 4.  Gynaecomastia--pathophysiology, diagnosis and treatment.

Authors:  Harmeet S Narula; Harold E Carlson
Journal:  Nat Rev Endocrinol       Date:  2014-08-12       Impact factor: 43.330

Review 5.  Gynecomastia and drugs: a critical evaluation of the literature.

Authors:  Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal:  Eur J Clin Pharmacol       Date:  2015-04-02       Impact factor: 2.953

6.  Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe.

Authors:  Sandra Shawarira-Bote; Tinei Shamu; Cleophas Chimbetete
Journal:  BMC Infect Dis       Date:  2019-08-13       Impact factor: 3.090

7.  Reversible Gynecomastia in HIV-Infected Man Treated With Triple Antiretroviral Therapy Containing Efavirenz: A Case Report.

Authors:  Mohammed Amine Essafi; Lamiaa Elazizi; Hayat Aynaou; Houda Salhi; Hanan El Ouahabi
Journal:  Cureus       Date:  2022-08-14

8.  The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi.

Authors:  Victor Singano; Alemayehu Amberbir; Daniela Garone; Christopher Kandionamaso; Jack Msonko; Monique van Lettow; Kondwani Kalima; Yamikani Mataka; Gift Kawalazira; Gabriel Mateyu; Aunex Kwekwesa; Alfred Matengeni; Joep J van Oosterhout
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.